1390 related articles for article (PubMed ID: 19730409)
1. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
Mofenson LM; Brady MT; Danner SP; Dominguez KL; Hazra R; Handelsman E; Havens P; Nesheim S; Read JS; Serchuck L; Van Dyke R; ; ; ; ;
MMWR Recomm Rep; 2009 Sep; 58(RR-11):1-166. PubMed ID: 19730409
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.
Kaplan JE; Benson C; Holmes KK; Brooks JT; Pau A; Masur H; ; ;
MMWR Recomm Rep; 2009 Apr; 58(RR-4):1-207; quiz CE1-4. PubMed ID: 19357635
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
Masur H; Kaplan JE; Holmes KK; ;
Ann Intern Med; 2002 Sep; 137(5 Pt 2):435-78. PubMed ID: 12617574
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
Kaplan JE; Masur H; Holmes KK; ;
MMWR Recomm Rep; 2002 Jun; 51(RR-8):1-52. PubMed ID: 12081007
[TBL] [Abstract][Full Text] [Related]
5. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America.
Benson CA; Kaplan JE; Masur H; Pau A; Holmes KK; ; ;
MMWR Recomm Rep; 2004 Dec; 53(RR-15):1-112. PubMed ID: 15841069
[TBL] [Abstract][Full Text] [Related]
6. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
Mofenson LM; Oleske J; Serchuck L; Van Dyke R; Wilfert C; ; ;
MMWR Recomm Rep; 2004 Dec; 53(RR-14):1-92. PubMed ID: 15577752
[TBL] [Abstract][Full Text] [Related]
7. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
Mofenson LM; Oleske J; Serchuck L; Van Dyke R; Wilfert C
Clin Infect Dis; 2005 Feb; 40 Suppl 1():S1-84. PubMed ID: 15655768
[TBL] [Abstract][Full Text] [Related]
8. Executive Summary: Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children: Recommendations From the National Institutes of Health, the Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
Siberry GK; Abzug MJ; Nachman S;
J Pediatric Infect Dis Soc; 2013 Dec; 2(4):293-308. PubMed ID: 26619492
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
[TBL] [Abstract][Full Text] [Related]
11. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
12. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.
Masur H; Brooks JT; Benson CA; Holmes KK; Pau AK; Kaplan JE; ; ;
Clin Infect Dis; 2014 May; 58(9):1308-11. PubMed ID: 24585567
[TBL] [Abstract][Full Text] [Related]
13. Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons.
Ryom L; Boesecke C; Gisler V; Manzardo C; Rockstroh JK; Puoti M; Furrer H; Miro JM; Gatell JM; Pozniak A; Behrens G; Battegay M; Lundgren JD;
HIV Med; 2016 Feb; 17(2):83-8. PubMed ID: 26548563
[TBL] [Abstract][Full Text] [Related]
14. What's new in the 2009 US guidelines for prevention and treatment of opportunistic infections among adults and adolescents with HIV?
Brooks JT; Kaplan JE; Masur H
Top HIV Med; 2009; 17(3):109-14. PubMed ID: 19675369
[TBL] [Abstract][Full Text] [Related]
15. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention.
MMWR Recomm Rep; 1995 Apr; 44(RR-4):1-11. PubMed ID: 7565543
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
Siberry GK; Abzug MJ; Nachman S; Brady MT; Dominguez KL; Handelsman E; Mofenson LM; Nesheim S; ; National Institutes of Health ; Centers for Disease Control and Prevention ; HIV Medicine Association of the Infectious Diseases Society of America ; Pediatric Infectious Diseases Society ; American Academy of Pediatrics
Pediatr Infect Dis J; 2013 Nov; 32 Suppl 2(0 2):i-KK4. PubMed ID: 24569199
[No Abstract] [Full Text] [Related]
17. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.
Dankner WM; Lindsey JC; Levin MJ;
Pediatr Infect Dis J; 2001 Jan; 20(1):40-8. PubMed ID: 11176565
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
[TBL] [Abstract][Full Text] [Related]
19. Malaria Surveillance - United States, 2017.
Mace KE; Lucchi NW; Tan KR
MMWR Surveill Summ; 2021 Mar; 70(2):1-35. PubMed ID: 33735166
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel.
Günthard HF; Saag MS; Benson CA; del Rio C; Eron JJ; Gallant JE; Hoy JF; Mugavero MJ; Sax PE; Thompson MA; Gandhi RT; Landovitz RJ; Smith DM; Jacobsen DM; Volberding PA
JAMA; 2016 Jul; 316(2):191-210. PubMed ID: 27404187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
